Revisiting 2024 box office predictions highlights missed expectations for “Mufasa,” “Joker,” “Inside Out 2,” “Deadpool” and ...

There’s some surprising Jewish history to be found at this annual attraction, where model trains traverse a mini New York ...

Guggenheim has recently raised Guardant Health Inc (GH) stock to Buy rating, as announced on June 28, 2024, according to Finviz. Earlier, on June 3, 2024, Jefferies had resumed the stock to Buy, ...

First Stamford Place is the new home of Guggenheim Partners' Connecticut office. Photo courtesy of Newmark Group STAMFORD – The ...

2024 was an “on” year for biennials and the calendar was packed with blockbuster shows and market events that took the Artnet ...

The most valuable U.S. team sponsorship during live broadcasts in 2024 belonged to the Los Angeles Dodgers, according to a ...

Michael Morris, Guggenheim Securities analyst, joins 'Squawk on the Street' to discuss what's at stake for Netflix, some of ...

St. Paul writer Kao Kalia Yang, author of this year's "Where Rivers Part," "Caged," "The Diamond Explorer" and "The Rock in ...

Fintel reports that on December 20, 2024, Guggenheim initiated coverage of Reddit (NYSE:RDDT) with a Buy recommendation.

The Guggenheim's Orphism exhibition includes more than 90 artworks on display in its iconic rotunda, celebrating the 1910s ...

Cryoport (CYRX), and Sartorius (SARTF) stocks win buy from Guggenheim while Maravai LifeSciences (MRVI) was granted a neutral rating. Read more here.

Guggenheim analyst Subbu Nambi initiated coverage of Danaher (DHR) with a Buy rating and $275 price target as the firm expands its ...